A Drug & Medical Device Recall And/Or Safety Alert Has Been Issued: Dialysate Concentrates Used in Hemodialysis: Safety Communication – Alkali Dosing Errors. According to the Food & Drug Administration FDA’s MedWatch:
Risk of elevated bicarbonate levels in patients undergoing hemodialysis, which can contribute to metabolic alkalosis, a significant risk factor associated with cardiopulmonary arrest, low blood pressure, hypokalemia, hypoxemia, hypercapnia, and cardiac arrhythmia.
For more information on the drug or medical device recall or safety alert, read the Food & Drug Administration’s FDA’s drug or medical device recall or safety alert: Dialysate Concentrates Used in Hemodialysis: Safety Communication – Alkali Dosing Errors.
To report an adverse reaction, problem or other issue with a drug or medical device, submit a drug or medical device complaint to the government at fda.gov or MedWatch.
If you have thoughts on the drug or medical device recall or safety alert, share your drug or medical device recall or safety alert comments below.